OKYO Pharma Stock (NASDAQ:OKYO)
Previous Close
$2.16
52W Range
$0.90 - $3.35
50D Avg
$2.22
200D Avg
$2.06
Market Cap
$78.23M
Avg Vol (3M)
$155.61K
Beta
-0.16
Div Yield
-
OKYO Company Profile
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.